• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Renin-angiotensin blockade in atrial fibrillation: where are we now?

作者信息

Shahid F, Lip G Y H, Shantsila E

机构信息

University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.

Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

出版信息

J Hum Hypertens. 2017 Jul;31(7):425-426. doi: 10.1038/jhh.2017.6.

DOI:10.1038/jhh.2017.6
PMID:28588316
Abstract
摘要

相似文献

1
Renin-angiotensin blockade in atrial fibrillation: where are we now?心房颤动中的肾素-血管紧张素阻断：我们目前处于什么阶段？
J Hum Hypertens. 2017 Jul;31(7):425-426. doi: 10.1038/jhh.2017.6.
2
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
Heart. 2018 Dec;104(23):1985. doi: 10.1136/heartjnl-2018-313929.
3
Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.回顾肾素-血管紧张素系统阻断的未来：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在预防心房颤动中的作用。
Can J Cardiol. 2010 Dec;26 Suppl E:21E-23E. doi: 10.1016/S0828-282X(10)71170-3.
4
[Atrial fibrillation and renin-angiotensin system].[心房颤动与肾素-血管紧张素系统]
Nihon Rinsho. 2007 Mar;65(3):569-74.
5
Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.维生素 D、心房颤动和肾素-血管紧张素-醛固酮系统之间的相互作用。
Am J Cardiol. 2018 Sep 1;122(5):780-784. doi: 10.1016/j.amjcard.2018.05.013. Epub 2018 Jun 2.
6
Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.肾素-血管紧张素系统阻断：作为环肺静脉隔离术治疗持续性心房颤动的辅助治疗方法
Med Hypotheses. 2007;69(4):767-72. doi: 10.1016/j.mehy.2007.02.016. Epub 2007 May 1.
7
Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.肾素-血管紧张素系统抑制剂对高血压患者新发心房颤动的预防作用：一项倾向评分匹配分析
J Hum Hypertens. 2017 Jul;31(7):450-456. doi: 10.1038/jhh.2016.95. Epub 2016 Dec 29.
8
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.阻断肾素-血管紧张素-醛固酮系统（RAAS）用于非瓣膜性心房颤动的一级预防：随机对照试验的系统评价和荟萃分析。
Int J Cardiol. 2013 Apr 30;165(1):17-24. doi: 10.1016/j.ijcard.2012.02.009. Epub 2012 Mar 14.
9
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.心房颤动中的血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂
Vnitr Lek. 2010 Nov;56(11):1138-41.
10
[The role of rennin-angiotensin-aldosterone system blockade in the prevention of nonvalvular atrial fibrillation].肾素-血管紧张素-醛固酮系统阻断在预防非瓣膜性心房颤动中的作用
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):293-4.

引用本文的文献

1
Interactions between atrial fibrosis and inflammation in atrial fibrillation.心房颤动中心房纤维化与炎症之间的相互作用。
Front Cardiovasc Med. 2025 Jul 10;12:1578148. doi: 10.3389/fcvm.2025.1578148. eCollection 2025.
2
Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review.开发针对线粒体功能障碍和氧化应激的心房颤动药理学治疗方法：范围综述。
Int J Mol Sci. 2023 Dec 30;25(1):535. doi: 10.3390/ijms25010535.
3
Genetics and Epigenetics of Atrial Fibrillation.

本文引用的文献

1
Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.肾素-血管紧张素系统抑制剂对高血压患者新发心房颤动的预防作用：一项倾向评分匹配分析
J Hum Hypertens. 2017 Jul;31(7):450-456. doi: 10.1038/jhh.2016.95. Epub 2016 Dec 29.
2
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.螺内酯对射血分数保留的房颤患者心肌纤维化的影响及对运动耐量的改善：IMPRESS-AF随机对照试验的原理与设计
BMJ Open. 2016 Oct 5;6(10):e012241. doi: 10.1136/bmjopen-2016-012241.
3
心房颤动的遗传学和表观遗传学。
Int J Mol Sci. 2020 Aug 10;21(16):5717. doi: 10.3390/ijms21165717.
4
Pulse pressure, arterial stiffening, and the efficacy of renin-angiotensin system inhibitor combinations.脉压、动脉僵硬度与肾素-血管紧张素系统抑制剂联合用药的疗效
J Hum Hypertens. 2018 Feb;32(2):165-166. doi: 10.1038/s41371-017-0014-1. Epub 2017 Dec 11.
Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study.
抗高血压药物对新发心房颤动风险的长期影响：一项纵向队列研究。
Hypertens Res. 2014 Oct;37(10):950-3. doi: 10.1038/hr.2014.104. Epub 2014 Jun 26.
4
Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database.使用达比加群欧洲标签的患者预后。RE-LY数据库的事后分析。
Thromb Haemost. 2014 May 5;111(5):933-42. doi: 10.1160/TH13-09-0734. Epub 2013 Dec 11.
5
TGF-β1, released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes.肌成纤维细胞分泌的 TGF-β1 可调节成年大鼠心室肌细胞钠钾通道的转录和功能。
PLoS One. 2013;8(2):e55391. doi: 10.1371/journal.pone.0055391. Epub 2013 Feb 5.
6
Left ventricular fibrosis in atrial fibrillation.心房颤动中的左心室纤维化。
Am J Cardiol. 2013 Apr 1;111(7):996-1001. doi: 10.1016/j.amjcard.2012.12.005. Epub 2013 Jan 17.
7
Stroke and thromboembolism in atrial fibrillation.心房颤动中的中风和血栓栓塞。
Circ J. 2012;76(10):2289-304. doi: 10.1253/circj.cj-12-1036. Epub 2012 Sep 19.
8
Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.心房颤动：心房颤动中肾素-血管紧张素系统的阻断
Nat Rev Cardiol. 2010 Aug;7(8):428-30. doi: 10.1038/nrcardio.2010.103.
9
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.血管紧张素受体阻滞剂替米沙坦对不耐受血管紧张素转换酶抑制剂的高危患者心血管事件的影响：一项随机对照试验。
Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29.
10
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.血管紧张素II受体阻滞剂降低新发房颤的发生率：VALUE试验
J Hypertens. 2008 Mar;26(3):403-11. doi: 10.1097/HJH.0b013e3282f35c67.